IL114949A - A multi-layered skin healing system that contains estradiol and a process for its production - Google Patents
A multi-layered skin healing system that contains estradiol and a process for its productionInfo
- Publication number
- IL114949A IL114949A IL11494995A IL11494995A IL114949A IL 114949 A IL114949 A IL 114949A IL 11494995 A IL11494995 A IL 11494995A IL 11494995 A IL11494995 A IL 11494995A IL 114949 A IL114949 A IL 114949A
- Authority
- IL
- Israel
- Prior art keywords
- estradiol
- matrix
- therapeutic system
- transdermal therapeutic
- water
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4429667A DE4429667C2 (de) | 1994-08-20 | 1994-08-20 | Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung |
Publications (2)
Publication Number | Publication Date |
---|---|
IL114949A0 IL114949A0 (en) | 1995-12-08 |
IL114949A true IL114949A (en) | 1998-12-27 |
Family
ID=6526231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11494995A IL114949A (en) | 1994-08-20 | 1995-08-15 | A multi-layered skin healing system that contains estradiol and a process for its production |
Country Status (22)
Country | Link |
---|---|
US (1) | US5902602A (pl) |
EP (1) | EP0776199B1 (pl) |
JP (1) | JP3825799B2 (pl) |
KR (1) | KR100401136B1 (pl) |
CN (1) | CN1078461C (pl) |
AT (1) | ATE185067T1 (pl) |
AU (1) | AU695970B2 (pl) |
CZ (1) | CZ289397B6 (pl) |
DE (2) | DE4429667C2 (pl) |
DK (1) | DK0776199T3 (pl) |
ES (1) | ES2139932T3 (pl) |
FI (1) | FI118720B (pl) |
GR (1) | GR3032218T3 (pl) |
HU (1) | HU226959B1 (pl) |
IL (1) | IL114949A (pl) |
MX (1) | MX9701302A (pl) |
NO (1) | NO313984B1 (pl) |
NZ (1) | NZ291813A (pl) |
PL (1) | PL180965B1 (pl) |
SK (1) | SK281626B6 (pl) |
WO (1) | WO1996005814A1 (pl) |
ZA (1) | ZA956925B (pl) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5698217A (en) * | 1995-05-31 | 1997-12-16 | Minnesota Mining And Manufacturing Company | Transdermal drug delivery device containing a desiccant |
DE19600347A1 (de) * | 1996-01-08 | 1997-07-10 | Lohmann Therapie Syst Lts | Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus |
DE19713141A1 (de) * | 1996-03-29 | 1997-10-30 | Labtec Gmbh | Transdermales System mit Melatonin |
DE19827732A1 (de) * | 1998-06-22 | 1999-12-23 | Rottapharm Bv | Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie |
US10493049B2 (en) | 2016-02-10 | 2019-12-03 | Niracle LLC | Applicator-based transdermal drug delivery system for administration of drugs in combination with topical formulations |
CN117545474A (zh) | 2021-11-08 | 2024-02-09 | 李维庸 | 一种用于向患者递送药物的透皮给药系统 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0040861B1 (en) * | 1979-01-11 | 1985-04-17 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix and method of its preparation |
US4438139A (en) * | 1979-08-14 | 1984-03-20 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estrogens |
CA1163559A (en) * | 1980-07-09 | 1984-03-13 | Alec D. Keith | Polymeric diffusion matrix for administration of drugs |
DE3333240A1 (de) * | 1983-09-12 | 1985-03-28 | Schering AG, 1000 Berlin und 4709 Bergkamen | Mittel zur transdermalen applikation von arzneimittelwirkstoffen |
ZA853488B (en) * | 1984-05-10 | 1986-12-30 | American Home Prod | Transdermal dosage form |
US4810499A (en) * | 1984-10-01 | 1989-03-07 | Biotek, Inc. | Transdermal drug delivery system and method |
US4788062A (en) * | 1987-02-26 | 1988-11-29 | Alza Corporation | Transdermal administration of progesterone, estradiol esters, and mixtures thereof |
US4816258A (en) * | 1987-02-26 | 1989-03-28 | Alza Corporation | Transdermal contraceptive formulations |
US4764379A (en) * | 1987-08-24 | 1988-08-16 | Alza Corporation | Transdermal drug delivery device with dual permeation enhancers |
US4863738A (en) * | 1987-11-23 | 1989-09-05 | Alza Corporation | Skin permeation enhancer compositions using glycerol monooleate |
US4855294A (en) * | 1988-09-06 | 1989-08-08 | Theratech, Inc. | Method for reducing skin irritation associated with drug/penetration enhancer compositions |
DD279818A1 (de) * | 1989-02-06 | 1990-06-20 | Jenapharm Veb | Verfahren zur herstellung eines medizinischen pflasters |
DE3933460A1 (de) * | 1989-10-06 | 1991-04-18 | Lohmann Therapie Syst Lts | Oestrogenhaltiges wirkstoffpflaster |
AR246186A1 (es) * | 1989-11-17 | 1994-07-29 | Beta Pharm Co | Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica. |
DE4210165A1 (de) * | 1991-07-30 | 1993-02-04 | Schering Ag | Transdermale therapeutische systeme |
US5518734A (en) * | 1991-09-25 | 1996-05-21 | Beta Pharmaceuticals Co. | Transdermal delivery system for estradiol and process for manufacturing said device |
DE4210711A1 (de) * | 1991-10-31 | 1993-05-06 | Schering Ag Berlin Und Bergkamen, 1000 Berlin, De | Transdermale therapeutische systeme mit kristallisationsinhibitoren |
DE69326461T2 (de) * | 1992-06-11 | 2000-05-04 | Theratech Inc., Salt Lake City | Verwendung von glyzerin zur dämpfung der transdermalen arzneimittelverabreichung |
ATE163262T1 (de) * | 1993-04-20 | 1998-03-15 | Hexal Ag | Wirkstoffplaster |
-
1994
- 1994-08-20 DE DE4429667A patent/DE4429667C2/de not_active Expired - Fee Related
-
1995
- 1995-08-12 CZ CZ1997509A patent/CZ289397B6/cs not_active IP Right Cessation
- 1995-08-12 HU HU9701729A patent/HU226959B1/hu not_active IP Right Cessation
- 1995-08-12 JP JP50775496A patent/JP3825799B2/ja not_active Expired - Lifetime
- 1995-08-12 MX MX9701302A patent/MX9701302A/es unknown
- 1995-08-12 US US08/632,490 patent/US5902602A/en not_active Expired - Lifetime
- 1995-08-12 NZ NZ291813A patent/NZ291813A/en not_active IP Right Cessation
- 1995-08-12 SK SK220-97A patent/SK281626B6/sk not_active IP Right Cessation
- 1995-08-12 WO PCT/EP1995/003201 patent/WO1996005814A1/de active IP Right Grant
- 1995-08-12 AT AT95929856T patent/ATE185067T1/de active
- 1995-08-12 ES ES95929856T patent/ES2139932T3/es not_active Expired - Lifetime
- 1995-08-12 DK DK95929856T patent/DK0776199T3/da active
- 1995-08-12 PL PL95319013A patent/PL180965B1/pl not_active IP Right Cessation
- 1995-08-12 CN CN95194677A patent/CN1078461C/zh not_active Expired - Fee Related
- 1995-08-12 AU AU33449/95A patent/AU695970B2/en not_active Ceased
- 1995-08-12 EP EP95929856A patent/EP0776199B1/de not_active Expired - Lifetime
- 1995-08-12 DE DE59506962T patent/DE59506962D1/de not_active Expired - Lifetime
- 1995-08-12 KR KR1019970701108A patent/KR100401136B1/ko not_active IP Right Cessation
- 1995-08-15 IL IL11494995A patent/IL114949A/en not_active IP Right Cessation
- 1995-08-18 ZA ZA956925A patent/ZA956925B/xx unknown
-
1997
- 1997-01-28 NO NO19970360A patent/NO313984B1/no not_active IP Right Cessation
- 1997-02-19 FI FI970701A patent/FI118720B/fi not_active IP Right Cessation
-
1999
- 1999-12-22 GR GR990403305T patent/GR3032218T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100281235B1 (ko) | 활성성분으로서 17-β-에스트라디올 무수물을 함유하는 경피치료계 | |
US5902602A (en) | Estradiol-TTS having water-binding additives | |
KR100549846B1 (ko) | 활성물질 스코폴라민 염기를 함유하는 경피 치료 시스템 | |
JP2001514226A5 (pl) | ||
AU700119B2 (en) | Estradiol-TTS having water-binding additives | |
CA2197867C (en) | Oestradiol transdermal therapeutic system comprising hygroscopic additives | |
US5932239A (en) | Transdermal therapeutic system with protection against hydrolysis | |
US5827245A (en) | Transdermal therapeutic system comprising the active subtance 17-β-Estradiol (Anhydrous) | |
US6623763B2 (en) | Pharmaceutical preparation adhering to the skin, in particular a transdermal therapeutic system for the release of 17-β-estradiol to the human organism | |
NO312878B1 (no) | Hudheftende farmasöytisk preparat, fremgangsmåte for fremstilling av samme, samt anvendelse av slike preparater | |
MXPA97001301A (en) | Transdermal therapeutic system containing estradiol comprising additives higrofili |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |